HYH Insider Trading Activity and SEC Form 4 Filings
HYH insider trading summary
No open-market insider purchases or sales of Halyard Health, Inc. (HYH) have been reported on SEC Form 4 in the past 12 months.
Latest HYH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 4, 2015 | Robert E Abernathy | Chairman and CEO | Buy | $311K (10,000 @ $31.06) |
| Sep 1, 2015 | Steven E Voskuil | SVP, Chief Financial Officer | Buy | $30K (1,000 @ $30.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.